Amplitude Vascular Systems (AVS) announced today that it enrolled the first patient(s) in the U.S. pivotal trial for its intravascular lithotripsy (IVL) technology. Boston-based Amplitude Vascular's POWER PAD II clinical study evaluates the safety of the Pulse IVL system. The company's pulsatile IVL (PIVL) therapy treats patients with moderate … [Read more...] about Amplitude Vascular enrolls first patient in IVL study
Amplitude Vascular Systems
AVS is developing a new method of intravascular lithotripsy
Amplitude Vascular Systems (AVS) is working on a new way to treat severely calcified arterial disease. The name of the company’s peripheral intravascular lithotripsy (IVL) system is Pulse. The Boston-based startup could start enrolling patients in an investigational device exemption (IDE) study as soon as next year. AVS Chief Operating … [Read more...] about AVS is developing a new method of intravascular lithotripsy
